Minimally invasive retroperitoneal lymph node dissection (MI-RPLND) and single dose adjuvant carboplatin for low volume stage 2 seminoma – 3 year outcomes

by D. Nicol, R. Huddart, A. Reid, S. Hazell, A. Sohaib, E. Mayer
Published 2020-07-01

A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer

by R. Portner, A. Bajaj, T. Elumalai, R. Huddart, V. Murthy, H. Nightingale, K. Patel, P. Sargos, Y. Song, P. Hoskin, A. Choudhury
Published 2021-11-01

Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer

by A. Hunt, I. Hanson, A. Dunlop, H. Barnes, L. Bower, J. Chick, C. Cruickshank, E. Hall, T. Herbert, R. Lawes, D. McQuaid, H. McNair, A. Mitchell, J. Mohajer, T. Morgan, U. Oelfke, G. Smith, S. Nill, R. Huddart, S. Hafeez
Published 2020-11-01